The UK's most valuable company remains a cornerstone for healthcare exposure, with 20 out of 24 analysts rating it a "Buy" due to a strong oncology pipeline and projected EPS growth of 60% by 2028.
Capitalizing on Asian wealth management growth, HSBC continues to benefit from strategic trade ties, recently reporting a 5.2% dividend yield.
With the FTSE 100 expected to pay a record in 2026, income seekers are focusing on these top-rated payers: ftse stocks to buy
A consistent favorite for passive income, currently yielding approximately 9.2% .
The UK stock market enters mid-2026 with a dual focus on earnings resilience and high-yield opportunities . While the FTSE 100 recently hit the psychological 10,000 mark , recent geopolitical tensions in the Middle East have introduced short-term volatility, leading to a temporary six-day losing streak for the index. FTSE 250 Index (MCX) 0.76% since Jan 2, 2026 As of Apr 27, 18:35 GMT+3 • Disclaimer Apr 27, 2026 Open22,583.17 Low22,562.99 52-wk high23,844.54 High22,682.27 Prev close22,582.81 52-wk low19,609.69 Top FTSE 100 Stocks to Watch The UK's most valuable company remains a cornerstone
For investors seeking higher growth, the mid-cap index offers a and exposure to niche sectors: How to turn a SIPP into £3,000 of monthly passive income
Analysts are currently highlighting a mix of defensive giants and high-growth turnaround stories: The UK stock market enters mid-2026 with a
A classic defensive choice yielding 5.5% , supported by resilient cash flow and a "Buy" rating from platforms like TipRanks . Growth Potential in the FTSE 250